Actively Recruiting
Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial
Led by Second Xiangya Hospital of Central South University · Updated on 2025-09-05
40
Participants Needed
1
Research Sites
22 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To explore the safety and efficacy of attapulgite in the treatment of obese individuals or overweight/obese individuals with type 2 diabetes.
CONDITIONS
Official Title
Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 to 60 years, any sex or gender
- For obese individuals: BMI of 28.0 kg/m2 or higher
- For overweight or obese individuals with type 2 diabetes: BMI of 24.0 kg/m2 or higher
- For type 2 diabetes patients: HbA1c between 7.0% and 10.0% or fasting blood glucose between 7.0 mmol/l and 13.3 mmol/l at screening
- Stable diabetes treatment for 6 months or longer
You will not qualify if you...
- Type 1 diabetes, monogenic diabetes, or diabetes caused by pancreatic injury or other secondary causes
- Severe diabetic complications in the 3 months before the study, such as severe hypoglycemia, diabetic ketoacidosis, or infections
- Use of products affecting weight in the past 3 months or planned during the study
- Weight fluctuation greater than 5 kg or 10% in the past 3 months
- Obesity or overweight caused by endocrine disorders like thyroid problems or Cushing's syndrome
- Uncontrolled high blood pressure or severe heart, liver, or kidney problems
- History of gastrointestinal surgery in the past year or other surgeries in the past 6 months, including bariatric surgery
- Chronic digestive disorders or conditions affecting digestion or absorption
- Cancer history in the past 5 years or serious immune system disorders
- Use of probiotics, prebiotics, or antibiotics in the 3 months before enrollment
- Alcohol abuse or yogurt consumption within 2 weeks before or during the study
- History of psychiatric or infectious diseases
- Pregnancy, breastfeeding, or plans for pregnancy during the study
- Participation in other clinical trials in the past 3 months
- Any other condition that the investigator feels prevents participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Changsha, Hunan, China, 410011
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here